The International HHV-6 Protest
and Teach-in At Harvard
During the HHV-6 Foundation's 9th International
Conference on HHV-6 & 7
During the HHV-6 Foundation's 9th International
Conference on HHV-6 & 7
November 9-11, 2015
First protest outside the cocktail reception Sunday, November 8th from 5:00pm – 7:00pm
First protest outside the cocktail reception Sunday, November 8th from 5:00pm – 7:00pm
(More to come.)
More on the HHV-6 Conference here.
40.
The right not to be lied to about the role of an HHV-6 cover-up in a
massive HIV Fraud Ponzi Scheme that in a number of ways resembles the
Tuskegee Syphilis Experiment and Nazi medicine.
ORGANIZING COMMITTEE, SESSION CHAIRS & INVITED SPEAKERS (LIST IN FORMATION)
Philip E. Pellett, PhD, Wayne State University, Co-Chair
Louis Flamand, PhD, MBA, Laval University, Co-Chair
Anthony L. Komaroff, MD, Harvard Medical School, CME Chair & Host
Dharam Ablashi, DVM, HHV-6 Foundation
Henri Agut, MD, PhD, Groupe Hospitalier Pitié-Salpêtrière
Michael Boeckh, MD, PhD, Fred Hutchinson Cancer Research Center
Mary T. Caserta, MD, University of Rochester Medical Center
Vincent Descamps, MD, Bichat Claude Bernard Hospital
Dario DiLuca, PhD, University of Ferrara
Leon G. Epstein, MD, Northwestern University, Feinberg School of Medicine
Niza Frenkel, PhD, Tel Aviv University
Agnes Gautheret-Dejean, MD, PhD, Groupe Hospitalier Pitie-Salpetriere
Ursula Gompels, MSc, PhD, London School of Hygiene and Tropical Medicine
Per Höllsberg, MD, Aarhus University
S. David Hudnall, MD, Yale University School of Medicine
Amy Hudson, PhD, Medical College of Wisconsin
Steven Jacobson, PhD, National Institute of Neurological Disorders and Stroke
Ruth Jarrett, MD, University of Glasgow
Benedikt Kaufer, PhD, Free University of Berlin
Irmeli Lautenschlager, MD, PhD, Helsinki University Hospital and University of Helsinki
Ann Leen, PhD, Baylor College of Medicine
Per Ljungman, MD, PhD, Karolinska University Hospital
Paolo Lusso, MD, PhD , National Institute of Allergy and Infectious Diseases
G. Peter Medveczky, MD, University of South Florida
Yasuko Mori, MD, PhD, Kobe University Graduate School of Medicine
Lieve Naesens, PhD , Rega Institute, Katholieke Universiteit Leuven
Raymund R. Razonable, MD, College of Medicine, Mayo Clinic
Nicola Royle, PhD, University of Leicester
Lawrence J. Stern, PhD, University of Massachusetts Medical School
Koichi Yamanishi, MD, PhD, Osaka University
Tetsushi Yoshikawa, MD, Fujita Health University School of Medicine
Katherine N. Ward, MD, University College London
Danielle Zerr, MD, University of Washington & Seattle Children’s Hospital
Sponsored by: HHV-6 Foundation, Dharam Ablashi, Scientific Director
Philip E. Pellett, PhD, Wayne State University, Co-Chair
Louis Flamand, PhD, MBA, Laval University, Co-Chair
Anthony L. Komaroff, MD, Harvard Medical School, CME Chair & Host
Dharam Ablashi, DVM, HHV-6 Foundation
Henri Agut, MD, PhD, Groupe Hospitalier Pitié-Salpêtrière
Michael Boeckh, MD, PhD, Fred Hutchinson Cancer Research Center
Mary T. Caserta, MD, University of Rochester Medical Center
Vincent Descamps, MD, Bichat Claude Bernard Hospital
Dario DiLuca, PhD, University of Ferrara
Leon G. Epstein, MD, Northwestern University, Feinberg School of Medicine
Niza Frenkel, PhD, Tel Aviv University
Agnes Gautheret-Dejean, MD, PhD, Groupe Hospitalier Pitie-Salpetriere
Ursula Gompels, MSc, PhD, London School of Hygiene and Tropical Medicine
Per Höllsberg, MD, Aarhus University
S. David Hudnall, MD, Yale University School of Medicine
Amy Hudson, PhD, Medical College of Wisconsin
Steven Jacobson, PhD, National Institute of Neurological Disorders and Stroke
Ruth Jarrett, MD, University of Glasgow
Benedikt Kaufer, PhD, Free University of Berlin
Irmeli Lautenschlager, MD, PhD, Helsinki University Hospital and University of Helsinki
Ann Leen, PhD, Baylor College of Medicine
Per Ljungman, MD, PhD, Karolinska University Hospital
Paolo Lusso, MD, PhD , National Institute of Allergy and Infectious Diseases
G. Peter Medveczky, MD, University of South Florida
Yasuko Mori, MD, PhD, Kobe University Graduate School of Medicine
Lieve Naesens, PhD , Rega Institute, Katholieke Universiteit Leuven
Raymund R. Razonable, MD, College of Medicine, Mayo Clinic
Nicola Royle, PhD, University of Leicester
Lawrence J. Stern, PhD, University of Massachusetts Medical School
Koichi Yamanishi, MD, PhD, Osaka University
Tetsushi Yoshikawa, MD, Fujita Health University School of Medicine
Katherine N. Ward, MD, University College London
Danielle Zerr, MD, University of Washington & Seattle Children’s Hospital
Sponsored by: HHV-6 Foundation, Dharam Ablashi, Scientific Director
More on the HHV-6 Conference here.
The HHV-6 Rights of Man
1. The right not to be lied to about the role of HHV-6 in AIDS.
2. The right not to be lied to about the role of HHV-6 in Chronic Fatigue Syndrome.
3. The right not to be lied to about the role of HHV-6 in Autism.
4.The right not to be lied to about the role of HHV-6 in Multiple Sclerosis.
5. The right not to be lied to about the role of HHV-6 in Brain Cancer.
6. The right not to be lied to about the role of HHV-6 in Heart Disease.
7. The right not to be lied to about the role of HHV-6 in Encephalitis.
8. The right not to be lied to about the role of HHV-6 in Cognitive Dysfunction.
9. The right not to be lied to about the role of HHV-6 in Drug Hypersensitivity Syndrome.
10. The right not to be lied to about the role of HHV-6 in Bone Marrow Suppression.
11. The right not to be lied to about the role of HHV-6 in Lymphadenopathy.
12. The right not to be lied to about the role of HHV-6 in Colitis.
13. The right not to be lied to about the role of HHV-6 in Endocrine Disorders.
14. The right not to be lied to about the role of HHV-6 in Liver Disease.
15. The right not to be lied to about the role of HHV-6 in Hodgkin's Lymphoma.
16. The right not to be lied to about the role of HHV-6 in Glioma.
17. The right not to be lied to about the role of HHV-6 in Cervical Cancer.
18. The right not to be lied to about the role of HHV-6 in Hypogammaglobulinemia.
19. The right not to be lied to about the role of HHV-6 in Optic Neuritis.
20. The right not to be lied to about the role of HHV-6 in Microangiopathy.
21. The right not to be lied to about the role of HHV-6 in Mononucleosis.
22. The right not to be lied to about the role of HHV-6 in Uveitis.
23. The right not to be lied to about the role of HHV-6 in Stevens-Johnson Syndrome.
24. The right not to be lied to about the role of HHV-6 in Rhomboencephalitis.
25. The right not to be lied to about the role of HHV-6 in Limbic Encephalitis.
26. The right not to be lied to about the role of HHV-6 in Encephalomyelitis
27. The right not to be lied to about the role of HHV-6 in Pneumonitis.
28. The right not to be lied to about the role of HHV-6 in GVHD.
29. The right not to be lied to about the role of HHV-6 in Ideopathic Pneumonia.
30. The right not to be lied to about the role of HHV-6 in Pediatric Adrenocortical Tumors
31. The right not to be lied to about the role of HHV-6 in the reactivation of endogenous retroviruses.
32. The right not to be lied to about the impact of HHV-6 on T-Cells.
33. The right not to be lied to about the impact of HHV-6 on B-Cells
34. The right not to be lied to about the impact of HHV-6 on Epithelial Cells.
35. The right not to be lied to about the the impact of HHV-6 on Natural Killer Cells.
35. The right not to be lied to about the the impact of HHV-6 on Dendritic Cells.
36. The right not to be lied to about the the impact of HHV-6 infection of the brain.
37. The right not to be lied to about the the impact of HHV-6 infection of the liver.
38. The right not to lied to about the ability of HHV-6 to affect cytokine production.
39. The right not to be lied to about the ability of HHV-6 to affect Aortic and Heart Microvascular Endothelial cells.
The HHV-6 Cover-up Must End!
No comments:
Post a Comment